Hepatitis Monthly

Published by: Kowsar

Which Method is Superior in the Diagnosis of Nonalcoholic Fatty Liver and Steatohepatatis in Children?

Farkhonde Razmpour 1 , Mohsen Nematy 2 , Mahmoud Belghaisi Naseri 3 , Zahra Dehnavi 3 , Azita Ganji 4 , Hasan Ali Vatanparast 5 , Ali Taghipour 6 , Mohsen Azimi Nezhad 7 and Seyed Ali Alamdaran 8 , *
Authors Information
1 MD, PhD Candidate in Nutrition, Department of Clinical Nutrition, Mashhad University of Medical Sciences (MUMS), Mashhad, Iran
2 PhD Associated Professor in Nutrition Science, Department of Biochemistry and Nutrition, Mashhad University of Medical Sciences (MUMS), Mashhad, Iran
3 MSC Student of Nutrition Science, Department of Nutrition, Mashhad University of Medical Sciences (MUMS), Mashhad, Iran
4 MD, Assistant Professor of Gastroenterology, Gastroenterology and Hepatology Research Center, Mashhad University of Medicine Sciences (MUMS), Mashhad, Iran
5 MD, PhD, Associated Professor in Nutrition Science, College of Pharmacy and Nutrition, Saskatchewan University of Health Science, Saskatchewan, Canada
6 MD, PhD, Associated Professor of Epidemiology, Department of Epidemiology, Mashhad University of Medicine Sciences (MUMS), Mashhad, Iran
7 MD, PhD, Assistant Professor of Medical Genetics, Department of Basic Medicine Sciences, Neyshabur University of Medical Sciences (NUMS), Neyshabur, Iran
8 MD, Associated Professor of Radiology, Department of Radiology, Mashhad University of Medicine Sciences (MUMS), Mashhad, Iran
Article information
  • Hepatitis Monthly: October 2017, 17 (10); e13584
  • Published Online: August 6, 2017
  • Article Type: Review Article
  • Received: May 16, 2017
  • Accepted: July 22, 2017
  • DOI: 10.5812/hepatmon.13584

To Cite: Razmpour F, Nematy M, Belghaisi Naseri M, Dehnavi Z, Ganji A, et al. Which Method is Superior in the Diagnosis of Nonalcoholic Fatty Liver and Steatohepatatis in Children?, Hepat Mon. 2017 ;17(10):e13584. doi: 10.5812/hepatmon.13584.

Abstract
Copyright © 2017, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Methods
3. Conclusions
References
  • 1. Riley MR, Bass NM, Rosenthal P, Merriman RB. Underdiagnosis of pediatric obesity and underscreening for fatty liver disease and metabolic syndrome by pediatricians and pediatric subspecialists. J Pediatr. 2005; 147(6): 839-42[DOI][PubMed]
  • 2. Gupta R, Bhangoo A, Matthews NA, Anhalt H, Matta Y, Lamichhane B, et al. The prevalence of non-alcoholic fatty liver disease and metabolic syndrome in obese children. J Pediatr Endocrinol Metab. 2011; 24(11-12): 907-11[DOI][PubMed]
  • 3. Schwimmer JB, Celedon MA, Lavine JE, Salem R, Campbell N, Schork NJ, et al. Heritability of nonalcoholic fatty liver disease. Gastroenterology. 2009; 136(5): 1585-92[DOI][PubMed]
  • 4. Schwimmer JB, Behling C, Newbury R, Deutsch R, Nievergelt C, Schork NJ, et al. Histopathology of pediatric nonalcoholic fatty liver disease. Hepatology. 2005; 42(3): 641-9[DOI][PubMed]
  • 5. Louthan MV, Theriot JA, Zimmerman E, Stutts JT, McClain CJ. Decreased prevalence of nonalcoholic fatty liver disease in black obese children. J Pediatr Gastroenterol Nutr. 2005; 41(4): 426-9[DOI][PubMed]
  • 6. Nobili V, Alisi A, Panera N, Agostoni C. Low birth weight and catch-up-growth associated with metabolic syndrome: a ten year systematic review. Pediatr Endocrinol Rev. 2008; 6(2): 241-7[PubMed]
  • 7. Abdelmalek MF, Suzuki A, Guy C, Unalp-Arida A, Colvin R, Johnson RJ, et al. Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease. Hepatology. 2010; 51(6): 1961-71[DOI][PubMed]
  • 8. Adams LA, Feldstein AE. Non-invasive diagnosis of nonalcoholic fatty liver and nonalcoholic steatohepatitis. J Dig Dis. 2011; 12(1): 10-6[DOI][PubMed]
  • 9. Mencin AA, Lavine JE. Advances in pediatric nonalcoholic fatty liver disease. Pediatr Clin North Am. 2011; 58(6): 1375-92[DOI][PubMed]
  • 10. Vajro P, Lenta S, Socha P, Dhawan A, McKiernan P, Baumann U, et al. Diagnosis of nonalcoholic fatty liver disease in children and adolescents: position paper of the ESPGHAN Hepatology Committee. J Pediatr Gastroenterol Nutr. 2012; 54(5): 700-13[DOI][PubMed]
  • 11. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012; 55(6): 2005-23[DOI][PubMed]
  • 12. Mager DR, Patterson C, So S, Rogenstein CD, Wykes LJ, Roberts EA. Dietary and physical activity patterns in children with fatty liver. Eur J Clin Nutr. 2010; 64(6): 628-35[DOI][PubMed]
  • 13. Alisi A, Locatelli M, Nobili V. Nonalcoholic fatty liver disease in children. Curr Opin Clin Nutr Metab Care. 2010; 13(4): 397-402[DOI][PubMed]
  • 14. Nobili V, Svegliati-Baroni G, Alisi A, Miele L, Valenti L, Vajro P. A 360-degree overview of paediatric NAFLD: recent insights. J Hepatol. 2013; 58(6): 1218-29[DOI][PubMed]
  • 15. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002; 346(16): 1221-31[DOI][PubMed]
  • 16. Angulo P. Long-term mortality in nonalcoholic fatty liver disease: is liver histology of any prognostic significance? Hepatology. 2010; 51(2): 373-5[DOI][PubMed]
  • 17. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005; 41(6): 1313-21[DOI][PubMed]
  • 18. Eddy DM. A manual for assessing health practices and designing practice guidelines. 1996;
  • 19. McCarthy HD, Jarrett KV, Crawley HF. The development of waist circumference percentiles in British children aged 5.0-16.9 y. Eur J Clin Nutr. 2001; 55(10): 902-7[DOI][PubMed]
  • 20. Lin YC, Chang PF, Yeh SJ, Liu K, Chen HC. Risk factors for liver steatosis in obese children and adolescents. Pediatr Neonatol. 2010; 51(3): 149-54[DOI][PubMed]
  • 21. Lebensztejn DM, Wierzbicka A, Socha P, Pronicki M, Skiba E, Werpachowska I, et al. Cytokeratin-18 and hyaluronic acid levels predict liver fibrosis in children with non-alcoholic fatty liver disease. Acta Biochim Pol. 2011; 58(4): 563-6[PubMed]
  • 22. Tominaga K, Fujimoto E, Suzuki K, Hayashi M, Ichikawa M, Inaba Y. Prevalence of non-alcoholic fatty liver disease in children and relationship to metabolic syndrome, insulin resistance, and waist circumference. Environ Health Prev Med. 2009; 14(2): 142-9[DOI][PubMed]
  • 23. Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther. 2011; 34(3): 274-85[DOI][PubMed]
  • 24. Oh S, Benson A, Grossman J, Nasser I, Curry MP, Afdhal NH. Non-invasive markers of fibrotic nonalcoholic steatohepatitis. Gastroen . 2003; 124(4): 743[DOI]
  • 25. Sopher A, Shen W, Pietrobelli A. Human body composition. 2005; 2: 129-400
  • 26. Higgins PB, Gower BA, Hunter GR, Goran MI. Defining health-related obesity in prepubertal children. Obes Res. 2001; 9(4): 233-40[DOI][PubMed]
  • 27. Yang HR, Chang EJ. Insulin resistance, body composition, and fat distribution in obese children with nonalcoholic fatty liver disease. Asia Pac J Clin Nutr. 2016; 25(1): 126-33[DOI][PubMed]
  • 28. Nobili V, Reale A, Alisi A, Morino G, Trenta I, Pisani M, et al. Elevated serum ALT in children presenting to the emergency unit: Relationship with NAFLD. Dig Liver Dis. 2009; 41(10): 749-52[DOI][PubMed]
  • 29. Siest G, Schiele F, Galteau MM, Panek E, Steinmetz J, Fagnani F, et al. Aspartate aminotransferase and alanine aminotransferase activities in plasma: statistical distributions, individual variations, and reference values. Clin Chem. 1975; 21(8): 1077-87[PubMed]
  • 30. Patton HM, Sirlin C, Behling C, Middleton M, Schwimmer JB, Lavine JE. Pediatric nonalcoholic fatty liver disease: a critical appraisal of current data and implications for future research. J Pediatr Gastroenterol Nutr. 2006; 43(4): 413-27[DOI][PubMed]
  • 31. Manco M, Marcellini M, Devito R, Comparcola D, Sartorelli MR, Nobili V. Metabolic syndrome and liver histology in paediatric non-alcoholic steatohepatitis. Int J Obes (Lond). 2008; 32(2): 381-7[DOI][PubMed]
  • 32. Patel DA, Srinivasan SR, Xu JH, Chen W, Berenson GS. Persistent elevation of liver function enzymes within the reference range is associated with increased cardiovascular risk in young adults: the Bogalusa Heart Study. Metabolism. 2007; 56(6): 792-8[DOI][PubMed]
  • 33. Barlow SE, Dietz WH. Obesity evaluation and treatment: Expert Committee recommendations. The Maternal and Child Health Bureau, Health Resources and Services Administration and the Department of Health and Human Services. Pediatrics. 1998; 102(3)[PubMed]
  • 34. Burgert TS, Taksali SE, Dziura J, Goodman TR, Yeckel CW, Papademetris X, et al. Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat. J Clin Endocrinol Metab. 2006; 91(11): 4287-94[DOI][PubMed]
  • 35. Schwimmer JB, Dunn W, Norman GJ, Pardee PE, Middleton MS, Kerkar N, et al. SAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease. Gastroenterology. 2010; 138(4): 1357-64[DOI][PubMed]
  • 36. Kinugasa A, Tsunamoto K, Furukawa N, Sawada T, Kusunoki T, Shimada N. Fatty liver and its fibrous changes found in simple obesity of children. J Pediatr Gastroenterol Nutr. 1984; 3(3): 408-14[DOI][PubMed]
  • 37. Atabek ME. Diagnosis of non-alcoholic fatty liver disease in obese children. J Pediatr Endocrinol Metab. 2012; 25(5-6): 613[DOI][PubMed]
  • 38. Schwimmer JB. Clinical advances in pediatric nonalcoholic fatty liver disease. Hepatology. 2016; 63(5): 1718-25[DOI][PubMed]
  • 39. Cortez-Pinto H, Camilo ME, Baptista A, De Oliveira AG, De Moura MC. Non-alcoholic fatty liver: another feature of the metabolic syndrome? Clin Nutr. 1999; 18(6): 353-8[DOI][PubMed]
  • 40. Park HS, Han JH, Choi KM, Kim SM. Relation between elevated serum alanine aminotransferase and metabolic syndrome in Korean adolescents. Am J Clin Nutr. 2005; 82(5): 1046-51[PubMed]
  • 41. Rodriguez G, Gallego S, Breidenassel C, Moreno LA, Gottrand F. Is liver transaminases assessment an appropriate tool for the screening of non-alcoholic fatty liver disease in at risk obese children and adolescents? Nutr Hosp. 2010; 25(5): 712-7[PubMed]
  • 42. Nobili V, Parkes J, Bottazzo G, Marcellini M, Cross R, Newman D, et al. Performance of ELF serum markers in predicting fibrosis stage in pediatric non-alcoholic fatty liver disease. Gastroenterology. 2009; 136(1): 160-7[DOI][PubMed]
  • 43. Fitzpatrick E, Dhawan A. Noninvasive biomarkers in non-alcoholic fatty liver disease: current status and a glimpse of the future. World J Gastroenterol. 2014; 20(31): 10851-63[DOI][PubMed]
  • 44. Nobili V, Day C. Childhood NAFLD: a ticking time-bomb? Gut. 2009; 58(11): 1442[DOI][PubMed]
  • 45. Sartorio A, Del Col A, Agosti F, Mazzilli G, Bellentani S, Tiribelli C, et al. Predictors of non-alcoholic fatty liver disease in obese children. Eur J Clin Nutr. 2007; 61(7): 877-83[DOI][PubMed]
  • 46. Mandato C, Lucariello S, Licenziati MR, Franzese A, Spagnuolo MI, Ficarella R, et al. Metabolic, hormonal, oxidative, and inflammatory factors in pediatric obesity-related liver disease. J Pediatr. 2005; 147(1): 62-6[DOI][PubMed]
  • 47. Manco M, Marcellini M, Giannone G, Nobili V. Correlation of serum TNF-alpha levels and histologic liver injury scores in pediatric nonalcoholic fatty liver disease. Am J Clin Pathol. 2007; 127(6): 954-60[DOI][PubMed]
  • 48. Nobili V, Manco M, Ciampalini P, Diciommo V, Devito R, Piemonte F, et al. Leptin, free leptin index, insulin resistance and liver fibrosis in children with non-alcoholic fatty liver disease. Eur J Endocrinol. 2006; 155(5): 735-43[DOI][PubMed]
  • 49. Alisi A, Cianfarani S, Manco M, Agostoni C, Nobili V. Non-alcoholic fatty liver disease and metabolic syndrome in adolescents: pathogenetic role of genetic background and intrauterine environment. Ann Med. 2012; 44(1): 29-40[DOI][PubMed]
  • 50. Malik R, Chang M, Bhaskar K, Nasser I, Curry M, Schuppan D, et al. The clinical utility of biomarkers and the nonalcoholic steatohepatitis CRN liver biopsy scoring system in patients with nonalcoholic fatty liver disease. J Gastroenterol Hepatol. 2009; 24(4): 564-8[DOI][PubMed]
  • 51. Bugianesi E, Pagotto U, Manini R, Vanni E, Gastaldelli A, de Iasio R, et al. Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity. J Clin Endocrinol Metab. 2005; 90(6): 3498-504[DOI][PubMed]
  • 52. Oruc N, Ozutemiz O, Yuce G, Akarca US, Ersoz G, Gunsar F, et al. Serum procalcitonin and CRP levels in non-alcoholic fatty liver disease: a case control study. BMC Gastroenterol. 2009; 9: 16[DOI][PubMed]
  • 53. Hui JM, Farrell GC, Kench JG, George J. High sensitivity C-reactive protein values do not reliably predict the severity of histological changes in NAFLD. Hepatology. 2004; 39(5): 1458-9[DOI][PubMed]
  • 54. Hui JM, Hodge A, Farrell GC, Kench JG, Kriketos A, George J. Beyond insulin resistance in NASH: TNF-alpha or adiponectin? Hepatology. 2004; 40(1): 46-54[DOI][PubMed]
  • 55. Feldstein AE, Alkhouri N, De Vito R, Alisi A, Lopez R, Nobili V. Serum cytokeratin-18 fragment levels are useful biomarkers for nonalcoholic steatohepatitis in children. Am J Gastroenterol. 2013; 108(9): 1526-31[DOI][PubMed]
  • 56. Feldstein AE, Wieckowska A, Lopez AR, Liu YC, Zein NN, McCullough AJ. Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study. Hepatology. 2009; 50(4): 1072-8[DOI][PubMed]
  • 57. Younossi ZM, Jarrar M, Nugent C, Randhawa M, Afendy M, Stepanova M, et al. A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH). Obes Surg. 2008; 18(11): 1430-7[DOI][PubMed]
  • 58. Carter-Kent C, Yerian LM, Brunt EM, Angulo P, Kohli R, Ling SC, et al. Nonalcoholic steatohepatitis in children: a multicenter clinicopathological study. Hepatology. 2009; 50(4): 1113-20[DOI][PubMed]
  • 59. Akcam M, Boyaci A, Pirgon O, Koroglu M, Dundar BN. Importance of the liver ultrasound scores in pubertal obese children with nonalcoholic fatty liver disease. Clin Imaging. 2013; 37(3): 504-8[DOI][PubMed]
  • 60. Valenti L, Alisi A, Galmozzi E, Bartuli A, Del Menico B, Alterio A, et al. I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease. Hepatology. 2010; 52(4): 1274-80[DOI][PubMed]
  • 61. Romeo S, Kozlitina J, Xing C, Pertsemlidis A, Cox D, Pennacchio LA, et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet. 2008; 40(12): 1461-5[DOI][PubMed]
  • 62. Yuan X, Waterworth D, Perry JR, Lim N, Song K, Chambers JC, et al. Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes. Am J Hum Genet. 2008; 83(4): 520-8[DOI][PubMed]
  • 63. Valenti L, Al-Serri A, Daly AK, Galmozzi E, Rametta R, Dongiovanni P, et al. Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease. Hepatology. 2010; 51(4): 1209-17[DOI][PubMed]
  • 64. Sookoian S, Pirola CJ. Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease. Hepatology. 2011; 53(6): 1883-94[DOI][PubMed]
  • 65. Valenti L, Alisi A, Nobili V. I148M PNPLA3 variant and progressive liver disease: A new paradigm in hepatology. Hepatology. 2012; [DOI][PubMed]
  • 66. Speliotes EK, Butler JL, Palmer CD, Voight BF, Giant Consortium , M. IGen Consortium , et al. PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease. Hepatology. 2010; 52(3): 904-12[DOI][PubMed]
  • 67. Romeo S, Sentinelli F, Cambuli VM, Incani M, Congiu T, Matta V, et al. The 148M allele of the PNPLA3 gene is associated with indices of liver damage early in life. J Hepatol. 2010; 53(2): 335-8[DOI][PubMed]
  • 68. Santoro N, Kursawe R, D'Adamo E, Dykas DJ, Zhang CK, Bale AE, et al. A common variant in the patatin-like phospholipase 3 gene (PNPLA3) is associated with fatty liver disease in obese children and adolescents. Hepatology. 2010; 52(4): 1281-90[DOI][PubMed]
  • 69. Goran MI, Walker R, Le KA, Mahurkar S, Vikman S, Davis JN, et al. Effects of PNPLA3 on liver fat and metabolic profile in Hispanic children and adolescents. Diabetes. 2010; 59(12): 3127-30[DOI][PubMed]
  • 70. Giudice EM, Grandone A, Cirillo G, Santoro N, Amato A, Brienza C, et al. The association of PNPLA3 variants with liver enzymes in childhood obesity is driven by the interaction with abdominal fat. PLoS One. 2011; 6(11)[DOI][PubMed]
  • 71. Santoro N, Savoye M, Kim G, Marotto K, Shaw MM, Pierpont B, et al. Hepatic fat accumulation is modulated by the interaction between the rs738409 variant in the PNPLA3 gene and the dietary omega6/omega3 PUFA intake. PLoS One. 2012; 7(5)[DOI][PubMed]
  • 72. Alkhouri N, Sedki E, Alisi A, Lopez R, Pinzani M, Feldstein AE, et al. Combined paediatric NAFLD fibrosis index and transient elastography to predict clinically significant fibrosis in children with fatty liver disease. Liver Int. 2013; 33(1): 79-85[DOI][PubMed]
  • 73. Vos MB. Is it time to advance pediatric NAFLD diagnosis to the magnetic resonance imaging era? Hepatology. 2015; 61(6): 1779-80[DOI][PubMed]
  • 74. Alavian SM, Mohammad-Alizadeh AH, Esna-Ashari F, Ardalan G, Hajarizadeh B. Non-alcoholic fatty liver disease prevalence among school-aged children and adolescents in Iran and its association with biochemical and anthropometric measures. Liver Int. 2009; 29(2): 159-63[DOI][PubMed]
  • 75. Shannon A, Alkhouri N, Carter-Kent C, Monti L, Devito R, Lopez R, et al. Ultrasonographic quantitative estimation of hepatic steatosis in children With NAFLD. J Pediatr Gastroenterol Nutr. 2011; 53(2): 190-5[DOI][PubMed]
  • 76. Nobili V, Della Corte C, Monti L, Alisi A, Feldstein A. The use of ultrasound in clinical setting for children affected by NAFLD: is it safe and accurate? Ital J Pediatr. 2011; 37: 36[DOI][PubMed]
  • 77. Thavorn K, Coyle D. Transient Elastography and Controlled Attenuation Parameter for Diagnosing Liver Fibrosis and Steatosis in Ontario: An Economic Analysis. Ont Health Technol Assess Ser. 2015; 15(19): 1-58[PubMed]
  • 78. de Ledinghen V, Vergniol J, Foucher J, El-Hajbi F, Merrouche W, Rigalleau V. Feasibility of liver transient elastography with FibroScan using a new probe for obese patients. Liver Int. 2010; 30(7): 1043-8[DOI][PubMed]
  • 79. Andersen ES, Christensen PB, Weis N. Transient elastography for liver fibrosis diagnosis. Eur J Intern Med. 2009; 20(4): 339-42[DOI][PubMed]
  • 80. Roulot D, Czernichow S, Le Clesiau H, Costes JL, Vergnaud AC, Beaugrand M. Liver stiffness values in apparently healthy subjects: influence of gender and metabolic syndrome. J Hepatol. 2008; 48(4): 606-13[DOI][PubMed]
  • 81. Nobili V, Vizzutti F, Arena U, Abraldes JG, Marra F, Pietrobattista A, et al. Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis. Hepatology. 2008; 48(2): 442-8[DOI][PubMed]
  • 82. Loomba R, Sirlin CB, Schwimmer JB, Lavine JE. Advances in pediatric nonalcoholic fatty liver disease. Hepatology. 2009; 50(4): 1282-93[DOI][PubMed]
  • 83. Cho Y, Tokuhara D, Morikawa H, Kuwae Y, Hayashi E, Hirose M, et al. Transient Elastography-Based Liver Profiles in a Hospital-Based Pediatric Population in Japan. PLoS One. 2015; 10(9)[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments